diabetes
Fractyl Health Expects to Launch Clinical Trial of Type 2 Diabetes Gene Therapy in 2025
While the company is prioritizing RJVA-001 and a lead program in obesity, it's pausing some R&D efforts and laying off 17 percent of its workforce.
Ovation.io Collecting WGS, Clinical Data From 8,500 Patients on GLP-1 Meds
The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.
The firm is also studying PTG-007 in patients with early-stage type 1 diabetes, but is looking for a partner for the pivotal trial.
As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role for biomarkers to guide their use.
Giostar Gearing up for Phase II Trial of Type 2 Diabetes Stem Cell Therapy in US
The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.